Association Between Left Ventricle Ejection Fraction and Vitamin D Levels in Congestive Heart Failure; A Cross Sectional Study

  • Betul Ozdemir Nigde Omer Halisdemir University
Keywords:
Heart failure; Ejection fraction; Vitamin D

Abstract

   

Objective: Congestive heart failure (HF) is a chronic disease that incidence is growing in the population. Vitamin D effects on directly myocardial cells. The aim of this study was to investigate the association between vitamin D levels with ejection fraction of left vetricule.

Methods: The study population consisted of 101 patients admitted with heart failure. Age, gender, and demographic characteristics (diabetes mellitus, hypertension, smoking-nonsmoking, coronary artery disease) of all patients were recorded. In all patients for blood analyses vitamin D, creatine, crp and lipid profile were studied. And all patients were studied echocardiography.

Results: HF patients, in our population 35 (34.7%) patient is female and 66 (65.3%) patient is male. The mean age of our patients was calculated as 67.4± 12.9 years. Our patients laboratory parameters mean were measured for vitamin D 24.3±17.3 ng/ml. LVEF mean was measured 31.8±9.5. In our study group LVEF and vitamin D was correlated with each other

Conclusions: Vitamin D and LVEF had a positive correlation in heart failure patients. It may be occured with the protective effect of vitamin D or consequence of hipovitaminosis.

 

References

Brondum-Jacobsen, P., Benn, M., Jensen, G.B., Nordestgaard, B.G. 2012. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: Population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb. Vasc. Biol. 32: 2794–2802. DOI:10.1161/ATVBAHA.112.248039; PMID:22936341.

Cozzolino M, Ketteler M, Zehnder D. 2010. The vitamin D system: a crosstalk between the heart and kidney. Eur J Heart Fail. 12: 1031-41. DOI: 10.1093/eurjhf/hfq112; PMID: 20605845.
DOI:10.1161/HYPERTENSIONAHA.107.087288; PMID:17372031.

Forman, J.P.; Curhan, G.C.; Taylor, E.N. 2008. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 52: 828–832. DOI:10.1161/HYPERTENSIONAHA.108.117630; PMID:18838623.

Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. 2007. Plasma 25-hydroxyvitamin D levels and risk of incidenthypertension. Hypertension. 49:1063–1069.

Holick, M.F. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266–281. DOI:10.1056/NEJMra070553; PMID:17634462.

Judd S.E., Tangpricha V. 2009. Vitamin D deficiency and risk for cardiovascular disease. Am. J. Med. Sci. 338:40–44. DOI:10.1097%2FMAJ.0b013e3181aaee91; PMID:19593102.

Kestenbaum B., Katz R., De Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., Jenny N.S., Siscovick D.S. 2011. Vitamin D, Parathyroid hormone, and cardiovascular events among older adults. J. Am. Coll. Cardiol. 58: 1433–1441. DOI:10.1016/j.jacc.2011.03.069; PMID:21939825.

Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. 2008. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 102:1540–1544. DOI:10.1016/j.amjcard.2008.06.067; PMID:19026311.

Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, et al. 2011. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 13: 619-25. DOI:10.1093/eurjhf/hfr032; PMID: 21543375.

Lugg S.T., Howells P.A., Thickett D.R.. 2015. Optimal vitamin D supplementation levels for cardiovascular disease protection. Dis. Markers. 1:10. DOI:10.1155/2015/864370; PMID:26435569.

Mozaffarian, D, Benjamin EF, Go AS, et al. 2016. American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 Update: A Report From the American Heart Association. Circulation. 133:38-360. DOI: 10.1161/CIR.0000000000000350; PMID:26673558.

Muscogiuri G., Nuzzo V., Gatti A., Zuccoli A., Savastano S., Di Somma C., Pivonello R., Orio F., Colao A. 2015. Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? Endocrine. 51:2, 268–273. DOI:10.1007/s12020-015-0609-7; PMID:25931413.

Pilz S, Tomaschitz A, Drechsler C, Dekker JM, Marz W. 2010. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res. 54: 1103-13. DOI: 10.1002/mnfr.200900474; PMID: 20352623.

Skaaby T., Husemoen L.L.N., Pisinger C., Jørgensen T., Thuesen B.H., Fenger M., Linneberg A., 2013. Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine. 43:618–625. DOI:10.1007/s12020-012-9805-x; PMID: 23015273.

Skaaby T., Husemoen L.L.N., Pisinger C., Jørgensen T., Thuesen B.H., Rasmussen K., Fenger M., Rossing P., Linneberg A. 2013. Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine. 44: 473–480. DOI:10.1007/s12020-013-9887-0; PMID:23377775.

Tsuprykov, O., Chen, X., Hocher, C.F., Skoblo, R., Lianghong, Y., Hocher, B. 2018. Why should we measure free 25(OH) vitamin D? J. Steroid Biochem. Mol. Biol. 180: 87–104. DOI: 10.1016/j.jsbmb.2017.11.014; PMID: 29217467.

Wang L., Song Y., Manson J.E., Pilz S., März W., Michaëlsson K., Lundqvist A., Jassal S.K., Barrett-Connor E., Zhang C., Eaton C.B., May H.T., Anderson J.L., Sesso H.D.. 2012. Circulating levels of 25hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5:819–829. DOI:10.1161/CIRCOUTCOMES.112.967604; PMID: 23149428.

Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. 2003. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 41:105–112. DOI:10.1016/s0735-1097(02)02624-4; PMID:12570952.
Published
2020-06-26
How to Cite
1.
Ozdemir B. Association Between Left Ventricle Ejection Fraction and Vitamin D Levels in Congestive Heart Failure; A Cross Sectional Study. J Pharm Care. 8(2):50-52.
Section
Original Article(s)